Nurix Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
34.09
|
|
Average Rating
|
4.36
|
|
# Strong Buys
|
5
|
|
# Buys
|
5
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-08-31
|
-0.98
|
-0.90
|
0.08
|
8.16%
|
|
2022-05-31
|
-0.99
|
-1.01
|
-0.02
|
-2.02%
|
|
2022-02-28
|
-0.88
|
-0.95
|
-0.07
|
-7.95%
|
|
2021-11-30
|
-0.69
|
-0.85
|
-0.16
|
-23.19%
|
|
2021-08-31
|
-0.63
|
-0.65
|
-0.02
|
-3.17%
|
|
2021-05-31
|
-0.54
|
-0.60
|
-0.06
|
-11.11%
|
|
2021-02-28
|
-0.46
|
-0.63
|
-0.17
|
-36.96%
|
|
2020-11-30
|
-0.54
|
-0.51
|
0.03
|
5.56%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-11-30
|
-2.86
|
|
2021-11-30
|
-2.73
|
|
2020-11-30
|
-4.10
|